Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,518 public trials 2,834 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia

NCT04948463

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations: Royal Children's Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

NCT01315132

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

NCT05002621

Conditions: Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP

NCT04948333

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: Novartis Investigative Site CABA, Buenos Aires, Argentina

Novartis Investigative Site Buenos Aires, Argentina

Novartis Investigative Site Graz, Austria

Novartis Investigative Site Linz, Austria

View all 48 locations

View Trial Details

Completed

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

NCT03441958

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond Montreal, Quebec, Canada

View Trial Details

Completed

A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL

NCT02135133

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma

NCT01615029

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Boston, Massachusetts, United States

Copenhagen Ø, Denmark

Vejle, Denmark

Lille, France

View Trial Details

Completed

Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)

NCT04926285

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: University of Illinois Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study

NCT04580563

Conditions: Blood Coagulation Disorders, Cardiovascular Diseases, Coagulopathy, +16 more
Locations: Hôpitaux Universitaires de Strasbourg Strasbourg, France

View Trial Details

Completed

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04225156

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Investigator Site 0010045 Washington D.C., District of Columbia, United States

Investigator Site 0010037 Ocala, Florida, United States

Investigator Site 0010042 Iowa City, Iowa, United States

Investigator Site 0010040 Columbus, Ohio, United States

View all 87 locations

View Trial Details